Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as CRF antagonists

Details for Australian Patent Application No. 2005257486 (hide)

Owner Taisho Pharmaceutical Co., Ltd.

Inventors Nozawa, Dai; Okubo, Taketoshi; De Bruyn, Marcel, F., L.; Kennis, Ludo, E., J.; Nakazato, Atsuro

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005257486

PCT Pub. Number WO2006/001501

Priority 2004-188129 25.06.04 JP

Filing date 24 June 2005

Wipo publication date 5 January 2006

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2006/001501 Priority application(s): WO2006/001501

2 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005257487-Malignant tumor local infiltration inhibitor containing batroxobin

2005257484-Metastin derivatives and use thereof